Nephro-Urology Monthly

Published by: Kowsar

FDG PET/CT in Prostate Cancer: A Valuable Method to Detect the Primary and Metastatic Tumor Sites and to Monitor Cancer Response to Hormonal Therapy

Alexander Hinev 1 , * , Borislav Chaushev 2 and Aneliya Klisarova 2
Authors Information
1 Department of Surgery, Clinic of Urology, Varna Medical University, Varna, Bulgaria
2 Department of Nuclear Medicine, Metabolic Therapy and Radiotherapy, Varna Medical University, Varna, Bulgaria
Article information
  • Nephro-Urology Monthly: September 01, 2012, 4 (4); 644-645
  • Published Online: September 24, 2012
  • Article Type: Letter
  • Received: February 21, 2012
  • Revised: March 2, 2012
  • Accepted: March 10, 2012
  • DOI: 10.5812/numonthly.4539

To Cite: Hinev A, Chaushev B, Klisarova A. FDG PET/CT in Prostate Cancer: A Valuable Method to Detect the Primary and Metastatic Tumor Sites and to Monitor Cancer Response to Hormonal Therapy, Nephro-Urol Mon. 2012 ; 4(4):644-645. doi: 10.5812/numonthly.4539.

Copyright © 2012, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Footnotes
References
  • 1. Joshi P, Lele V. Prostatic Adenocarcinoma Masquerading as Generalized Lymphadenopathy and Mimicking Lymphoma on FDG PET/CT: Diagnosis, Staging, and Evaluation of Therapy Response by FDG PET/CT. Nephro-Urol Mon. 2012; 4(2): 482-4[DOI]
  • 2. Hinev A, Klissarova A, Ghenev P, Kolev N, Chaushev B, Chankov P, et al. Radioisotopic detection of sentinel lymph nodes in clinically localized high-risk prostate cancer. J BUON. 2009; 14(4): 661-7[PubMed]
  • 3. Han EJ, H OJ, Choi WH, Yoo IR, Chung SK. Significance of incidental focal uptake in prostate on 18-fluoro-2-deoxyglucose positron emission tomography CT images. Br J Radiol. 2010; 83(995): 915-20[DOI][PubMed]
  • 4. Minamimoto R, Uemura H, Sano F, Terao H, Nagashima Y, Yamanaka S, et al. The potential of FDG-PET/CT for detecting prostate cancer in patients with an elevated serum PSA level. Ann Nucl Med. 2011; 25(1): 21-7[DOI][PubMed]
  • 5. Li G, Dhawan M, Takalkar AM, Lilien DL. FDG PET/CT imaging suggests lymphoma involving prostate may be more resistant to treatment. Clin Nucl Med. 2011; 36(3): 255-7[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments